000			02170 a2200649 4500
005			20250517045939.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a1029-2403
024	7		_a10.3109/10428194.2015.1075019 _2doi
040			_aNLM _beng _cNLM
100	1		_aHolkova, Beata
245	0	0	_aPhase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. _h[electronic resource]
260			_bLeukemia & lymphoma _c2016
300			_a635-43 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiomarkers
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytokines _xblood
650	0	4	_aDrug Monitoring
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHydroxamic Acids _xadministration & dosage
650	0	4	_aLymphoma, B-Cell _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aOligopeptides _xadministration & dosage
650	0	4	_aRetreatment
650	0	4	_aTreatment Outcome
650	0	4	_aVorinostat
700	1		_aKmieciak, Maciej
700	1		_aBose, Prithviraj
700	1		_aYazbeck, Victor Y
700	1		_aBarr, Paul M
700	1		_aTombes, Mary Beth
700	1		_aShrader, Ellen
700	1		_aWeir-Wiggins, Caryn
700	1		_aRollins, April D
700	1		_aCebula, Erin M
700	1		_aPierce, Emily
700	1		_aHerr, Megan
700	1		_aSankala, Heidi
700	1		_aHogan, Kevin T
700	1		_aWan, Wen
700	1		_aFeng, Changyong
700	1		_aPeterson, Derick R
700	1		_aFisher, Richard I
700	1		_aGrant, Steven
700	1		_aFriedberg, Jonathan W
773	0		_tLeukemia & lymphoma _gvol. 57 _gno. 3 _gp. 635-43
856	4	0	_uhttps://doi.org/10.3109/10428194.2015.1075019 _zAvailable from publisher's website
999			_c25180201 _d25180201